𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells viaPPP2R5Cdown-regulation

✍ Scribed by Shen, Qi; Liu, Sichu; Chen, Yu; Yang, Lijian; Chen, Shaohua; Wu, Xiuli; Li, Bo; Lu, Yuhong; Zhu, Kanger; Li, Yangqiu

Book ID
121623685
Publisher
BioMed Central
Year
2013
Tongue
English
Weight
914 KB
Volume
6
Category
Article
ISSN
1756-8722

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

NF-ΞΊB inhibition triggers death of imati
NF-ΞΊB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants
✍ Nadia Lounnas; Catherine Frelin; NadΓ¨ge Gonthier; Pascal Colosetti; Anne Sirvent πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 521 KB

## Abstract The Bcr‐Abl inhibitor imatinib is the current first‐line therapy for all newly diagnosed chronic myeloid leukemia (CML). Nevertheless, resistance to imatinib emerges as CML progresses to an acute deadly phase implying that physiopathologically relevant cellular targets should be validat

Pml and TAp73 interacting at nuclear bod
Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells
✍ Jin-Hwang Liu; Chin-Cheng Liu; Chueh-Chuan Yen; Jyh-Pyng Gau; Wei-Shu Wang; Chen πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 837 KB

## Abstract Bcr‐abl signals for leukemogenesis of chronic myeloid leukemia (CML) and activates ras. Since the function of promyelocytic leukemia protein (pml) is provoked by ras to promote apoptosis and senescence in untransformed cells, the function is probably masked in CML. Imatinib specifically